Amid renewed buying interest in the broader equity markets, select domestic brokerage firms have identified key stocks across multiple sectors for potential short-term gains. Canara Bank Securities, SMIFS, and PL Capital have shared their top picks, citing strong technical patterns and parameters.
Top Stock Picks for Short-Term Gains
Here’s a breakdown of the recommended stocks and their associated targets and stop losses:
Urban Company
- Recommendation: Buy
- Current Market Price: Rs 172.70
- Target Price: Rs 185.70
- Stop Loss: Rs 164.10
Rationale: Urban Company Ltd recently broke above a downward-sloping trendline near Rs 162, indicating a potential trend reversal. The stock successfully retested the breakout zone around Rs 160, confirming the previous resistance has now become support. With the Relative Strength Index (RSI) at 61, bullish momentum is improving, suggesting further upside. Recommended by: Canara Bank Securities
Azad Engineering
- Recommendation: Buy
- Target Price: Rs 2,670 - Rs 2,950
- Stop Loss: Rs 2,250
Rationale: Azad Engineering Ltd has maintained a strong positive trend, despite a significant correction from its peak of Rs 3,125. The stock found support near Rs 2,250 and has since shown a positive candle formation with decent volume on the daily chart, improving its outlook. The RSI near the oversold zone signals a positive trend reversal. Recommended by: PL Capital
Indraprastha Gas
- Recommendation: Buy
- Current Market Price: Rs 148.20
- Target Price: Rs 159.30
- Stop Loss: Rs 140.80
Rationale: Indraprastha Gas Ltd broke above a downward-sloping trendline near Rs 143, signaling a potential trend reversal. A successful retest of the breakout zone around Rs 141 confirms that the prior resistance is now support. The RSI at 60 indicates improving bullish momentum with room for further gains. Recommended by: Canara Bank Securities
Bharat Petroleum Corporation (BPCL)
- Recommendation: Buy
- Current Market Price: Rs 300.80
- Target Price: Rs 331
- Stop Loss: Rs 285.75
Rationale: BPCL is exhibiting a constructive bullish setup, trading near a key breakout-retest zone after recovering from lower levels. Price action suggests healthy demand at support, indicating accumulation. The ongoing consolidation is seen as a healthy pause, allowing the stock to absorb supply before an upward move. Momentum indicators are stabilizing, supporting a positive bias as long as key support holds. Recommended by: SMIFS
Sun Pharmaceutical Industries
- Recommendation: Buy
- Current Market Price: Rs 1,881
- Target Price: Rs 2,033
- Stop Loss: Rs 1,756
Rationale: Sun Pharma has broken out of a downward-sloping channel and successfully retested the breakout levels, indicating positive momentum. The price has moved above all major moving averages, signaling an improving trend structure. The RSI is near the moderate zone at around 62, reflecting strong upward momentum. Volume expansion during the breakout phase adds credibility to the move. Recommended by: Canara Bank Securities
Disclaimer: This information is for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.